| Annual Financials | 2023 | 2024 | 2025 | 2026 | TTM |
Revenue  | 3 | 5 | 16 | 34 | 0 |
| Expenses | 2 | 4 | 12 | 27 | 0 |
| EBITDA | 1 | 1 | 4 | 7 | 0 |
| Operating Profit % | 21 % | 24 % | 23 % | 21 % | 0 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 1 | 0 |
| Profit Before Tax | 0 | 1 | 3 | 6 | 0 |
| Tax | 0 | 0 | 1 | 1 | 0 |
| Net Profit | 0 | 1 | 3 | 5 | 0 |
| EPS in ₹ | 7.79 | 22.83 | 6.88 | 9.35 | 0.00 |
Accretion Nutraveda
Accretion Nutraveda
270.00
-12.00
(-4.26%)
Market Cap
195.51 Cr
PE Ratio
-
Volume
3,000.00
Day High - Low
272.20 - 270.00
52W High-Low
313.00 - 150.10
Key Fundamentals
Market Cap
195.51 Cr
EPS
9.35
PE Ratio
-
PB Ratio
5.76
Book Value
49.00
EBITDA
7.00
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
14.29
Debt to Equity
0.20
Actual
Company News
View All News
Accretion Nutraveda Limited seeks shareholder approval for a postal ballot to increase borrowing limits to ₹500 crore and alter its MOA. E-voting runs from September 10 to October 9, 2026.
Accretion Nutraveda Ltd board approved alterations to its Memorandum of Association and enhanced borrowing limits on September 1, 2026. The proposals require shareholder approval via postal ballot.
Accretion Nutraveda holds 5th AGM on Aug 27
Aug 27, 2026
Aug 27, 2026Accretion Nutraveda Limited concluded its 5th AGM on August 27, 2026. Shareholders approved the adoption of financial statements for FY26 and reappointed key directors. The meeting was held via VC/OAVM.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,840.00 | #1 4,41,477.63 | 36.91 | #1 61,673.90 | 12.69 | #1 11,565 | 26.53 | 34.00 | |
9,322.00 | 2,47,469.81 | 85.36 | 11,067.00 | 13.95 | 2,568 | 65.50 | 63.65 | |
4,965.50 | 1,88,871.66 | 86.95 | 13,886.20 | 20.34 | 2,138 | 3.28 | 52.16 | |
1,119.10 | 1,12,607.65 | 24.28 | 27,657.90 | 17.64 | 5,026 | -34.90 | 45.64 | |
1,366.00 | 1,10,351.67 | 33.22 | 29,044.60 | 2.24 | 3,870 | -39.18 | 35.27 | |
1,969.00 | 1,06,297.76 | 95.94 | 6,867.80 | 22.01 | 890 | #1 123.93 | 68.28 | |
1,165.50 | 97,280.68 | 29.91 | 35,058.60 | 3.90 | 4,158 | -69.10 | 47.72 | |
1,679.80 | 96,651.98 | 25.88 | 34,145.20 | 5.56 | 3,503 | 25.21 | 57.04 | |
2,095.00 | 95,790.22 | #1 17.09 | 29,038.90 | #1 26.75 | 5,356 | 16.00 | 28.17 | |
2,280.00 | 94,163.08 | 44.87 | 14,636.40 | 14.85 | 1,938 | 29.13 | 37.57 |
Growth Rate
Revenue Growth
110.63 %
Net Income Growth
104.00 %
Cash Flow Change
-324.32 %
ROE
-71.13 %
ROCE
-63.21 %
EBITDA Margin (Avg.)
-10.82 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 4 | 5 | 11 | 42 |
| Fixed Assets | 2 | 1 | 2 | 2 |
| Current Assets | 3 | 3 | 9 | 30 |
| Capital Work in Progress | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets | 3 | 3 | 9 | 40 |
| Total Equity & Liabilities | 4 | 5 | 11 | 42 |
| Current Liabilities | 2 | 3 | 3 | 3 |
| Non Current Liabilities | 1 | 1 | 3 | 4 |
| Total Equity | 0 | 1 | 5 | 36 |
| Reserve & Surplus | -0 | 1 | 5 | 28 |
| Share Capital | 0 | 0 | 1 | 7 |
Cash Flow
| Cash Flow | 2023 | 2024 | 2025 | 2026 |
| Net Cash Flow | 0 | 0 | -0 | 1 |
| Investing Activities | 0 | -0 | -1 | -15 |
| Operating Activities | 1 | 0 | -2 | -9 |
| Financing Activities | -1 | 0 | 3 | 25 |
Share Holding
| % Holding | Sept 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Jun 2026 |
| Promoter | 100.00 % | 100.00 % | 73.48 % | 73.48 % | 73.48 % |
| FIIs | 0.00 % | 0.00 % | 6.04 % | 1.08 % | 1.08 % |
| DIIs | 0.00 % | 0.00 % | 6.51 % | 7.00 % | 6.11 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 10.48 % | 14.19 % | 15.77 % |
| Others | 0.00 % | 0.00 % | 3.49 % | 4.25 % | 3.56 % |
| No of Share Holders | 10 | 10 | 407 | 427 | 396 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 08 May 2026 |  Quarterly Result Announcement | NA | 08 May 2026 | 267.50 | 271.70 |
| 27 Aug 2026 |  Annual General Meeting | NA | 27 Aug 2026 | 283.95 | 278.00 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication2 days ago
2 days agoShareholder Meeting / Postal Ballot-Notice of Postal Ballot2 days ago
2 days agoDisclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 201510 days ago
10 days agoDisclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 01, 2026
Sep 01, 2026Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationSep 01, 2026
Sep 01, 2026Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 27, 2026
Aug 27, 2026Shareholder Meeting / Postal Ballot-Outcome of AGMAug 27, 2026
Aug 27, 2026Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Aug 06, 2026
Aug 06, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 05, 2026
Aug 05, 2026Notice Of The 5Th AGM Of The CompanyAug 04, 2026
Aug 04, 2026Reg. 34 (1) Annual Report.Aug 04, 2026
Aug 04, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 01, 2026
Aug 01, 2026Announcement Under Regulation 30 Of SEBI (LODR)- AwardJul 09, 2026
Jul 09, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 06, 2026
Jul 06, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 15, 2026
May 15, 2026Appointment Of Internal AuditorsMay 08, 2026
May 08, 2026Appointment Of Secretarial AuditorsMay 08, 2026
May 08, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 08, 2026
May 08, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 08, 2026
May 08, 2026Announcement under Regulation 30 (LODR)-Resignation of DirectorMay 08, 2026
May 08, 2026Announcement under Regulation 30 (LODR)-Resignation of DirectorMay 08, 2026
May 08, 2026Board Meeting Outcome for Outcome Of Board Meeting Financial Results 31St March 2026May 08, 2026
May 08, 2026Board Meeting Intimation for Board Meeting Intimation For Consider And Approve Audited Financial Results For The Year Ended On 31St March 2026May 01, 2026
May 01, 2026Clarification On Price MovementApr 30, 2026
Apr 30, 2026Clarification sought from Accretion Nutraveda LtdApr 29, 2026
Apr 29, 2026Confirmation Regarding Non-Applicability Of Large Corporate Disclosure RequirementsApr 29, 2026
Apr 29, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Apr 27, 2026
Apr 27, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2026
Apr 04, 2026Intimation For Change Of Corporate Identification Number (CIN) Of The Company.Apr 01, 2026
Apr 01, 2026Closure of Trading WindowMar 28, 2026
Mar 28, 2026Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 26, 2026
Mar 26, 2026Appointment Of Internal AuditorsMar 26, 2026
Mar 26, 2026Board Meeting Outcome for Outcome Of The Board MeetingMar 26, 2026
Mar 26, 2026Clarification On Price MovementFeb 20, 2026
Feb 20, 2026Clarification sought from Accretion Nutraveda LtdFeb 19, 2026
Feb 19, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 17, 2026
Feb 17, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 07, 2026
Feb 07, 2026Listing of Equity Shares of Accretion Nutraveda LtdFeb 04, 2026
Feb 04, 2026Technical Indicators
RSI(14)
Neutral 51.41
ATR(14)
Less Volatile 11.06
STOCH(9,6)
Neutral 21.27
STOCH RSI(14)
Oversold 18.02
MACD(12,26)
Bearish -1.34
ADX(14)
Weak Trend 13.06
UO(9)
Bearish 44.07
ROC(12)
Downtrend And Accelerating -9.90
WillR(14)
Neutral -65.26
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
